A 68-year-old Kansas woman died a day after receiving the CCP Virus (COVID) vaccine, according to the most recent press account of an anaphylactic response to the vaccine. The woman had an allergic reaction at a vaccination clinic site about 4 p.m. on Tuesday, March 23, according to EMS dispatch reports, said KMBC. She was injected with an EpiPen when she was having trouble breathing and listening.

The Vaccine Adverse Event Reporting System (VAERS) data showed 44,606 cases of adverse reactions to COVID vaccines between Dec. 14, 2020, and March 19, 2021, including 2,050 deaths and 7,095 serious injuries.

The woman only identified as Evans had an anaphylactic reaction during the waiting time after taking the injection, according to Kristi Zears of the Kansas Department of Health and Environment. She was admitted to the hospital and was pronounced dead the following day. Evans did not seem to have any existing medical problems, and the Kansas Health Department did not specify which COVID vaccine was given to her.

According to the CDC’s webpage, “The CDC follows up on any report of death to request additional information and learn more about what occurred and to determine whether the death was a result of the vaccine or unrelated.”

The only details the CDC has released so far on the review of COVID vaccine-related deaths and how such investigations were carried out is a COVID-19 Vaccine Safety Update issued by the Advisory Committee on Immunization Practices (ACIP) on Jan. 27.

The Defender approached the CDC on March 8 with concerns about COVID vaccine-related deaths and injuries. A list of questions was sent about how the CDC investigates confirmed injuries, the state of media-reported deaths, whether autopsies are performed, and the standard for deciding whether an accident is causally linked to a vaccine.

People wanted to know if health care providers are monitoring all COVID-related accidents and fatalities, and if there are any outreach programs in place to promote and enable proper and reliable reporting.

Sign up to receive our latest news!

By submitting this form, I agree to the terms.